Home › Calculator › CLDX Dividend Calculator 2026
CLDX Dividend Calculator 2026
No dividendHealthcareCelldex Therapeutics, Inc. · NASDAQ
Price: $29.25 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
Calculator settings
CLDX is not a dividend-focused stock
CLDX pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
CLDX Dividend Yield
Celldex Therapeutics, Inc. (CLDX) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When CLDX pays your bills
Year your monthly dividend income covers each expense (based on current settings)
About Celldex Therapeutics, Inc. (CLDX) — Dividend Analysis 2026
Celldex Therapeutics, Inc. is a biopharmaceutical company dedicated to developing antibody-based treatments, specifically monoclonal and bispecific antibodies, for a range of diseases. Their pipeline features therapeutic candidates aimed at both inflammatory conditions and various forms of cancer. Among their key clinical programs: CDX-0159 is a Phase I monoclonal antibody designed to bind to and inhibit the activity of the KIT receptor tyrosine kinase. CDX-1140 is a human agonist monoclonal antibody that targets CD40, a critical immune response activator found on immune cells such as dendritic cells, macrophages, and B cells, as well as on several cancer cell types. CDX-527 is a bispecific antibody that integrates Celldex's proprietary anti-PD-L1 and CD27 human antibodies. Its mechanism involves combining CD27 costimulation with blockade of the PD-L1/PD-1 pathway to prime and activate anti-tumor T-cell responses. The company has established several research collaborations and licensing agreements, including partnerships with the University of Southampton for developing human antibodies targeting CD27, Amgen Inc. for exclusive rights to CDX-301 and CD40 ligand, and Yale University. Incorporated in 1983, Celldex Therapeutics, Inc. is headquartered in Hampton, New Jersey.
CLDX Dividend & DRIP — Frequently Asked Questions
Does CLDX pay a dividend?
No. Celldex Therapeutics, Inc. (CLDX) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
How can I get dividend income instead of CLDX?
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
Does CLDX have a DRIP (dividend reinvestment plan)?
A DRIP reinvests dividends into new shares. CLDX has no regular dividend in our data, so there is nothing to reinvest.
Stocks similar to CLDX
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full CLDX DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open CLDX position with:
🌍 CLDX Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold CLDX.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 CLDX Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 CLDX Dividend Payment Schedule
CLDX pays quarterly — 4 times per year. Ex-div: —.
📊 CLDX vs Healthcare Benchmarks
How CLDX compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for CLDX sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ CLDX Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-06-25 | 90,000 | $34.09 | $3.07M | ||
| A-Award | 2026-06-25 | 93,000 | $34.09 | $3.17M | ||
| A-Award | 2026-06-25 | 57,000 | $34.09 | $1.94M | ||
| A-Award | 2026-06-25 | 95,000 | $34.09 | $3.24M | ||
| A-Award | 2026-06-25 | 93,000 | $34.09 | $3.17M | ||
| A-Award | 2026-06-25 | 95,000 | $34.09 | $3.24M | ||
| A-Award | 2026-06-25 | 100,000 | $34.09 | $3.41M | ||
| A-Award | 2026-06-25 | 20,000 | $34.09 | $681.8K | ||
| A-Award | 2026-06-25 | 115,000 | $34.09 | $3.92M | ||
| A-Award | 2026-06-25 | 375,000 | $34.09 | $12.78M |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Peer Group
Similar companies in the same sectorCompare CLDX with peers: CLDX vs ADAG · CLDX vs AGEN · CLDX vs CGEN
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the CLDX dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Celldex Therapeutics, Inc. (CLDX) is currently trading at $29.25, 35% below its 52-week high. It does not currently pay a regular dividend.
Does CLDX Pay a Dividend? Celldex Therapeutics, Inc. Dividend Status
Celldex Therapeutics, Inc. (CLDX) is a healthcare stock trading at $29.25. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
- Without a dividend, returns depend entirely on the share price.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest CLDX News
LiveProjected your CLDX DRIP returns?
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.